Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Smoking trajectories and risk of stroke until age of 50 years - The Northern Finland Birth Cohort 1966.

Rissanen I, Oura P, Paananen M, Miettunen J, Geerlings MI.

PLoS One. 2019 Dec 17;14(12):e0225909. doi: 10.1371/journal.pone.0225909. eCollection 2019.

2.

Intracranial Atherosclerotic Burden on 7T MRI Is Associated with Markers of Extracranial Atherosclerosis: The SMART-MR Study.

Zwartbol MHT, Geerlings MI, Ghaznawi R, Hendrikse J, van der Kolk AG; UCC-SMART Study Group.

AJNR Am J Neuroradiol. 2019 Dec;40(12):2016-2022. doi: 10.3174/ajnr.A6308. Epub 2019 Dec 5.

PMID:
31806592
3.

Risk factors of mortality in older patients with dementia in psychiatric care.

Golüke NMS, Geerlings MI, van de Vorst IE, Vaartjes IH, de Jonghe A, Bots ML, Koek HL.

Int J Geriatr Psychiatry. 2020 Feb;35(2):174-181. doi: 10.1002/gps.5232. Epub 2019 Dec 2.

4.

Risk factors for in-hospital mortality in patients with dementia.

Golüke NMS, van de Vorst IE, Vaartjes IH, Geerlings MI, de Jonghe A, Bots ML, Koek HL.

Maturitas. 2019 Nov;129:57-61. doi: 10.1016/j.maturitas.2019.08.007. Epub 2019 Aug 20.

PMID:
31547914
5.

Subjective cognitive decline, brain imaging biomarkers, and cognitive functioning in patients with a history of vascular disease: the SMART-Medea study.

Blom K, Koek HL, Zwartbol MHT, van der Graaf Y, Kesseler L, Biessels GJ, Geerlings MI; SMART Study Group.

Neurobiol Aging. 2019 Dec;84:33-40. doi: 10.1016/j.neurobiolaging.2019.07.011. Epub 2019 Jul 24.

6.

Progress update from the hippocampal subfields group.

Olsen RK, Carr VA, Daugherty AM, La Joie R, Amaral RSC, Amunts K, Augustinack JC, Bakker A, Bender AR, Berron D, Boccardi M, Bocchetta M, Burggren AC, Chakravarty MM, Chételat G, de Flores R, DeKraker J, Ding SL, Geerlings MI, Huang Y, Insausti R, Johnson EG, Kanel P, Kedo O, Kennedy KM, Keresztes A, Lee JK, Lindenberger U, Mueller SG, Mulligan EM, Ofen N, Palombo DJ, Pasquini L, Pluta J, Raz N, Rodrigue KM, Schlichting ML, Lee Shing Y, Stark CEL, Steve TA, Suthana NA, Wang L, Werkle-Bergner M, Yushkevich PA, Yu Q, Wisse LEM; Hippocampal Subfields Group.

Alzheimers Dement (Amst). 2019 Jun 13;11:439-449. doi: 10.1016/j.dadm.2019.04.001. eCollection 2019 Dec.

7.

Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial.

Witlox L, Schagen SB, de Ruiter MB, Geerlings MI, Peeters PHM, Koevoets EW, van der Wall E, Stuiver M, Sonke G, Velthuis MJ, Palen JAMV, Jobsen JJ, May AM, Monninkhof EM.

BMJ Open. 2019 Jun 20;9(6):e028117. doi: 10.1136/bmjopen-2018-028117.

8.

Microbleeds colocalize with enlarged juxtacortical perivascular spaces in amnestic mild cognitive impairment and early Alzheimer's disease: A 7 Tesla MRI study.

Bouvy WH, van Veluw SJ, Kuijf HJ, Zwanenburg JJ, Kappelle JL, Luijten PR, Koek HL, Geerlings MI, Biessels GJ; Utrecht Vascular Cognitive Impairment (VCI) Study Group.

J Cereb Blood Flow Metab. 2019 Mar 19:271678X19838087. doi: 10.1177/0271678X19838087. [Epub ahead of print]

PMID:
30890076
9.

Kidney Function and the Risk of Stroke and Dementia: The Rotterdam Study.

Koop-Nieuwelink C, Sedaghat S, Mutlu U, Licher S, Franco OH, Ikram MA, Geerlings MI, Ikram MK, Bos D.

J Alzheimers Dis. 2019;67(3):821-826. doi: 10.3233/JAD-181086.

PMID:
30664508
10.

Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting.

Chauhan G, Adams HHH, Satizabal CL, Bis JC, Teumer A, Sargurupremraj M, Hofer E, Trompet S, Hilal S, Smith AV, Jian X, Malik R, Traylor M, Pulit SL, Amouyel P, Mazoyer B, Zhu YC, Kaffashian S, Schilling S, Beecham GW, Montine TJ, Schellenberg GD, Kjartansson O, Guðnason V, Knopman DS, Griswold ME, Windham BG, Gottesman RF, Mosley TH, Schmidt R, Saba Y, Schmidt H, Takeuchi F, Yamaguchi S, Nabika T, Kato N, Rajan KB, Aggarwal NT, De Jager PL, Evans DA, Psaty BM, Rotter JI, Rice K, Lopez OL, Liao J, Chen C, Cheng CY, Wong TY, Ikram MK, van der Lee SJ, Amin N, Chouraki V, DeStefano AL, Aparicio HJ, Romero JR, Maillard P, DeCarli C, Wardlaw JM, Hernández MDCV, Luciano M, Liewald D, Deary IJ, Starr JM, Bastin ME, Muñoz Maniega S, Slagboom PE, Beekman M, Deelen J, Uh HW, Lemmens R, Brodaty H, Wright MJ, Ames D, Boncoraglio GB, Hopewell JC, Beecham AH, Blanton SH, Wright CB, Sacco RL, Wen W, Thalamuthu A, Armstrong NJ, Chong E, Schofield PR, Kwok JB, van der Grond J, Stott DJ, Ford I, Jukema JW, Vernooij MW, Hofman A, Uitterlinden AG, van der Lugt A, Wittfeld K, Grabe HJ, Hosten N, von Sarnowski B, Völker U, Levi C, Jimenez-Conde J, Sharma P, Sudlow CLM, Rosand J, Woo D, Cole JW, Meschia JF, Slowik A, Thijs V, Lindgren A, Melander O, Grewal RP, Rundek T, Rexrode K, Rothwell PM, Arnett DK, Jern C, Johnson JA, Benavente OR, Wasssertheil-Smoller S, Lee JM, Wong Q, Mitchell BD, Rich SS, McArdle PF, Geerlings MI, van der Graaf Y, de Bakker PIW, Asselbergs FW, Srikanth V, Thomson R, McWhirter R, Moran C, Callisaya M, Phan T, Rutten-Jacobs LCA, Bevan S, Tzourio C, Mather KA, Sachdev PS, van Duijn CM, Worrall BB, Dichgans M, Kittner SJ, Markus HS, Ikram MA, Fornage M, Launer LJ, Seshadri S, Longstreth WT Jr, Debette S; Stroke Genetics Network (SiGN), the International Stroke Genetics Consortium (ISGC), METASTROKE, Alzheimer's Disease Genetics Consortium (ADGC), and the Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium.

Neurology. 2019 Jan 16. pii: 10.1212/WNL.0000000000006851. doi: 10.1212/WNL.0000000000006851. [Epub ahead of print]

11.

Intracranial Vessel Wall Lesions on 7T MRI (Magnetic Resonance Imaging).

Zwartbol MHT, van der Kolk AG, Ghaznawi R, van der Graaf Y, Hendrikse J, Geerlings MI; SMART Study Group.

Stroke. 2019 Jan;50(1):88-94. doi: 10.1161/STROKEAHA.118.022509.

PMID:
30582831
12.

MRI phenotypes of the brain are related to future stroke and mortality in patients with manifest arterial disease: The SMART-MR study.

Jaarsma-Coes MG, Ghaznawi R, Hendrikse J, Slump C, Witkamp TD, van der Graaf Y, Geerlings MI, de Bresser J; Second Manifestations of ARTerial disease (SMART) Study group.

J Cereb Blood Flow Metab. 2020 Feb;40(2):354-364. doi: 10.1177/0271678X18818918. Epub 2018 Dec 14.

13.

The association between lacunes and white matter hyperintensity features on MRI: The SMART-MR study.

Ghaznawi R, Geerlings MI, Jaarsma-Coes MG, Zwartbol MH, Kuijf HJ, van der Graaf Y, Witkamp TD, Hendrikse J, de Bresser J.

J Cereb Blood Flow Metab. 2019 Dec;39(12):2486-2496. doi: 10.1177/0271678X18800463. Epub 2018 Sep 11.

14.

Hippocampal sulcal cavities: prevalence, risk factors and association with cognitive performance. The SMART-Medea study and PREDICT-MR study.

Blom K, Koek HL, van der Graaf Y, Zwartbol MHT, Wisse LEM, Hendrikse J, Biessels GJ, Geerlings MI; SMART Study Group.

Brain Imaging Behav. 2019 Aug;13(4):1093-1102. doi: 10.1007/s11682-018-9916-y.

15.

Hippocampal Calcifications: Risk Factors and Association with Cognitive Function.

de Brouwer EJM, Kockelkoren R, Claus JJ, de Jonghe A, Geerlings MI, Jongsma TEF, Mali WPTM, Hendrikse J, de Jong PA, Koek HL.

Radiology. 2018 Sep;288(3):815-820. doi: 10.1148/radiol.2018172588. Epub 2018 Jun 12.

PMID:
29893650
16.

White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis.

van den Berg E, Geerlings MI, Biessels GJ, Nederkoorn PJ, Kloppenborg RP.

J Alzheimers Dis. 2018;63(2):515-527. doi: 10.3233/JAD-170573. Review.

PMID:
29630548
17.

Automated Multi-Atlas Segmentation of Hippocampal and Extrahippocampal Subregions in Alzheimer's Disease at 3T and 7T: What Atlas Composition Works Best?

Xie L, Shinohara RT, Ittyerah R, Kuijf HJ, Pluta JB, Blom K, Kooistra M, Reijmer YD, Koek HL, Zwanenburg JJM, Wang H, Luijten PR, Geerlings MI, Das SR, Biessels GJ, Wolk DA, Yushkevich PA, Wisse LEM.

J Alzheimers Dis. 2018;63(1):217-225. doi: 10.3233/JAD-170932.

18.

Reply to: Late-Life Depression, Cortisol, and the Hippocampus: On the Need to Consider Depressive, Hippocampal, and Pharmacological Complexities.

Geerlings MI, Gerritsen L.

Biol Psychiatry. 2018 Jan 1;83(1):e25. doi: 10.1016/j.biopsych.2017.07.002. Epub 2017 Jul 12. No abstract available.

PMID:
28838558
19.

Physical Activity and Characteristics of the Carotid Artery Wall in High-Risk Patients-The SMART (Second Manifestations of Arterial Disease) Study.

Boss HM, van der Graaf Y, Visseren FLJ, Van den Berg-Vos RM, Bots ML, de Borst GJ, Cramer MJ, Kappelle LJ, Geerlings MI; SMART Study Group.

J Am Heart Assoc. 2017 Jul 23;6(7). pii: e005143. doi: 10.1161/JAHA.116.005143.

20.

Detection and characterization of small infarcts in the caudate nucleus on 7 Tesla MRI: The SMART-MR study.

Ghaznawi R, de Bresser J, van der Graaf Y, Zwartbol MH, Witkamp TD, Geerlings MI, Hendrikse J; SMART Study Group *.

J Cereb Blood Flow Metab. 2018 Sep;38(9):1609-1617. doi: 10.1177/0271678X17705974. Epub 2017 Apr 24.

21.

Cardiorespiratory fitness, cognition and brain structure after TIA or minor ischemic stroke.

Boss HM, Van Schaik SM, Witkamp TD, Geerlings MI, Weinstein HC, Van den Berg-Vos RM.

Int J Stroke. 2017 Oct;12(7):724-731. doi: 10.1177/1747493017702666. Epub 2017 Apr 6.

PMID:
28382852
22.

Late-Life Depression, Hippocampal Volumes, and Hypothalamic-Pituitary-Adrenal Axis Regulation: A Systematic Review and Meta-analysis.

Geerlings MI, Gerritsen L.

Biol Psychiatry. 2017 Sep 1;82(5):339-350. doi: 10.1016/j.biopsych.2016.12.032. Epub 2017 Jan 27. Review.

PMID:
28318491
23.

Do Lacunar Infarcts Have Different Aetiologies? Risk Factor Profiles of Lacunar Infarcts in Deep White Matter and Basal Ganglia: The Second Manifestations of ARTerial Disease-Magnetic Resonance Study.

Kloppenborg RP, Nederkoorn PJ, Grool AM, De Cocker LJ, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Cerebrovasc Dis. 2017;43(3-4):161-168. doi: 10.1159/000454782. Epub 2017 Jan 31.

24.

Cardiorespiratory Fitness after Transient Ischemic Attack and Minor Ischemic Stroke: Baseline Data of the MoveIT Study.

Boss HM, Deijle IA, Van Schaik SM, de Melker EC, van den Berg BTJ, Weinstein HC, Geerlings MI, Kappelle LJ, Van den Berg-Vos RM.

J Stroke Cerebrovasc Dis. 2017 May;26(5):1114-1120. doi: 10.1016/j.jstrokecerebrovasdis.2016.12.029. Epub 2017 Jan 12.

PMID:
28089564
25.

Hippocampal volume and the course of depressive symptoms over eight years of follow-up.

Buddeke J, Kooistra M, Zuithoff NP, Gerritsen L, Biessels GJ, van der Graaf Y, Geerlings MI; SMART Study Group.

Acta Psychiatr Scand. 2017 Jan;135(1):78-86. doi: 10.1111/acps.12662. Epub 2016 Nov 1.

PMID:
27800603
26.

Cerebral blood flow in small vessel disease: A systematic review and meta-analysis.

Shi Y, Thrippleton MJ, Makin SD, Marshall I, Geerlings MI, de Craen AJM, van Buchem MA, Wardlaw JM.

J Cereb Blood Flow Metab. 2016 Oct;36(10):1653-1667. Epub 2016 Aug 5. Review.

27.

The natural course of elevated levels of depressive symptoms in patients with vascular disease over eight years of follow-up. The SMART-Medea study.

Kooistra M, van der Graaf Y, Grool AM, Zuithoff NP, Jan Biessels G, Geerlings MI; SMART-MR Study Group.

J Affect Disord. 2016 Sep 15;202:95-101. doi: 10.1016/j.jad.2016.05.050. Epub 2016 May 24.

PMID:
27259081
28.

Perivascular spaces on 7 Tesla brain MRI are related to markers of small vessel disease but not to age or cardiovascular risk factors.

Bouvy WH, Zwanenburg JJM, Reinink R, Wisse LEM, Luijten PR, Kappelle LJ, Geerlings MI, Biessels GJ; Utrecht Vascular Cognitive Impairment (VCI) Study group.

J Cereb Blood Flow Metab. 2016 Oct;36(10):1708-1717. Epub 2016 May 6.

29.

Automated Hippocampal Subfield Segmentation at 7T MRI.

Wisse LE, Kuijf HJ, Honingh AM, Wang H, Pluta JB, Das SR, Wolk DA, Zwanenburg JJ, Yushkevich PA, Geerlings MI.

AJNR Am J Neuroradiol. 2016 Jun;37(6):1050-7. doi: 10.3174/ajnr.A4659. Epub 2016 Feb 4.

30.

Correction. SMART Study Group. Cerebellar cortical infarct cavities: correlation with risk factors and MRI markers of cerebrovascular disease.

De Cocker LJ, Kloppenborg RP, van der Graaf Y, Luijten PR, Hendrikse J, Geerlings MI.

Stroke. 2016 Feb;47(2):e38. doi: 10.1161/STR.0000000000000094. No abstract available.

PMID:
26811333
31.

The relation between apolipoprotein E (APOE) genotype and peripheral artery disease in patients at high risk for cardiovascular disease.

Koopal C, Geerlings MI, Muller M, de Borst GJ, Algra A, van der Graaf Y, Visseren FL; SMART Study Group.

Atherosclerosis. 2016 Mar;246:187-92. doi: 10.1016/j.atherosclerosis.2016.01.009. Epub 2016 Jan 11.

PMID:
26800308
32.

Erratum to "Subfields of the hippocampal formation at 7T MRI: In vivo volumetric assessment" [NeuroImage 61 (2012) 1043-1049].

Wisse LEM, Gerritsen L, Zwanenburg JJM, Kuijf HJ, Luijten PR, Biessels GJ, Geerlings MI.

Neuroimage. 2016 Jan 15;125:1176-1177. doi: 10.1016/j.neuroimage.2015.10.054. Epub 2015 Nov 6. No abstract available.

PMID:
28800683
33.

Clinical Manifestation of Depression after Stroke: Is It Different from Depression in Other Patient Populations?

de Man-van Ginkel JM, Hafsteinsdóttir TB, Lindeman E, Geerlings MI, Grobbee DE, Schuurmans MJ.

PLoS One. 2015 Dec 4;10(12):e0144450. doi: 10.1371/journal.pone.0144450. eCollection 2015.

34.

Prognosis of patients with dementia: results from a prospective nationwide registry linkage study in the Netherlands.

van de Vorst IE, Vaartjes I, Geerlings MI, Bots ML, Koek HL.

BMJ Open. 2015 Oct 28;5(10):e008897. doi: 10.1136/bmjopen-2015-008897. Erratum in: BMJ Open. 2016 May 24;6(5):e008897corr1.

35.

Hypertensive Target Organ Damage and Longitudinal Changes in Brain Structure and Function: The Second Manifestations of Arterial Disease-Magnetic Resonance Study.

van der Veen PH, Geerlings MI, Visseren FL, Nathoe HM, Mali WP, van der Graaf Y, Muller M; SMART Study Group.

Hypertension. 2015 Dec;66(6):1152-8. doi: 10.1161/HYPERTENSIONAHA.115.06268. Epub 2015 Oct 26.

PMID:
26503971
36.

Cerebellar Cortical Infarct Cavities: Correlation With Risk Factors and MRI Markers of Cerebrovascular Disease.

De Cocker LJ, Kloppenborg RP, van der Graaf Y, Luijten PR, Hendrikse J, Geerlings MI; SMART Study Group.

Stroke. 2015 Nov;46(11):3154-60. doi: 10.1161/STROKEAHA.115.010093. Epub 2015 Sep 17. Erratum in: Stroke. 2016 Feb;47(2):e38.

PMID:
26382175
37.

Salivary cortisol, brain volumes, and cognition in community-dwelling elderly without dementia.

Geerlings MI, Sigurdsson S, Eiriksdottir G, Garcia ME, Harris TB, Gudnason V, Launer LJ.

Neurology. 2015 Sep 15;85(11):976-83. doi: 10.1212/WNL.0000000000001931. Epub 2015 Aug 19.

38.

Cortical microinfarcts on 7 T MRI in patients with spontaneous intracerebral hemorrhage.

van Veluw SJ, Jolink WM, Hendrikse J, Geerlings MI, Luijten PR, Biessels GJ, Klijn CJ.

J Cereb Blood Flow Metab. 2015 Jul;35(7):1222. doi: 10.1038/jcbfm.2015.34. No abstract available.

39.

Cerebellar infarct patterns: The SMART-Medea study.

De Cocker LJ, Geerlings MI, Hartkamp NS, Grool AM, Mali WP, Van der Graaf Y, Kloppenborg RP, Hendrikse J; SMART study group.

Neuroimage Clin. 2015 Feb 9;8:314-21. doi: 10.1016/j.nicl.2015.02.001. eCollection 2015.

40.

Longitudinal relationship between cerebral small-vessel disease and cerebral blood flow: the second manifestations of arterial disease-magnetic resonance study.

van der Veen PH, Muller M, Vincken KL, Hendrikse J, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Stroke. 2015 May;46(5):1233-8. doi: 10.1161/STROKEAHA.114.008030. Epub 2015 Mar 24.

PMID:
25804924
41.

Physical Activity and Vascular Events and Mortality in Patients with Vascular Disease.

Boss HM, Kappelle LJ, Van Der Graaf Y, Kooistra M, Visseren FL, Geerlings MI.

Med Sci Sports Exerc. 2015 Nov;47(11):2359-65. doi: 10.1249/MSS.0000000000000666.

PMID:
25793539
42.

Hippocampal disconnection in early Alzheimer's disease: a 7 tesla MRI study.

Wisse LE, Reijmer YD, ter Telgte A, Kuijf HJ, Leemans A, Luijten PR, Koek HL, Geerlings MI, Biessels GJ; Utrecht Vascular Cognitive Impairment (VCI) Study Group.

J Alzheimers Dis. 2015;45(4):1247-56. doi: 10.3233/JAD-142994.

PMID:
25697703
43.

Hemoglobin, hematocrit, and changes in cerebral blood flow: the Second Manifestations of ARTerial disease-Magnetic Resonance study.

van der Veen PH, Muller M, Vincken KL, Westerink J, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Neurobiol Aging. 2015 Mar;36(3):1417-23. doi: 10.1016/j.neurobiolaging.2014.12.019. Epub 2014 Dec 20.

PMID:
25618615
44.

Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: towards a harmonized segmentation protocol.

Yushkevich PA, Amaral RS, Augustinack JC, Bender AR, Bernstein JD, Boccardi M, Bocchetta M, Burggren AC, Carr VA, Chakravarty MM, Chételat G, Daugherty AM, Davachi L, Ding SL, Ekstrom A, Geerlings MI, Hassan A, Huang Y, Iglesias JE, La Joie R, Kerchner GA, LaRocque KF, Libby LA, Malykhin N, Mueller SG, Olsen RK, Palombo DJ, Parekh MB, Pluta JB, Preston AR, Pruessner JC, Ranganath C, Raz N, Schlichting ML, Schoemaker D, Singh S, Stark CE, Suthana N, Tompary A, Turowski MM, Van Leemput K, Wagner AD, Wang L, Winterburn JL, Wisse LE, Yassa MA, Zeineh MM; Hippocampal Subfields Group (HSG).

Neuroimage. 2015 May 1;111:526-41. doi: 10.1016/j.neuroimage.2015.01.004. Epub 2015 Jan 14.

45.

Major depressive episodes over the course of 7 years and hippocampal subfield volumes at 7 tesla MRI: the PREDICT-MR study.

Wisse LE, Biessels GJ, Stegenga BT, Kooistra M, van der Veen PH, Zwanenburg JJ, van der Graaf Y, Geerlings MI.

J Affect Disord. 2015 Apr 1;175:1-7. doi: 10.1016/j.jad.2014.12.052. Epub 2014 Dec 30.

PMID:
25589378
46.

Arterial stiffness and progression of structural brain changes: The SMART-MR study.

Jochemsen HM, Muller M, Bots ML, Scheltens P, Vincken KL, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Neurology. 2015 Feb 3;84(5):448-55. doi: 10.1212/WNL.0000000000001201. Epub 2014 Dec 31.

PMID:
25552578
47.

Cognitive performance and the course of depressive symptoms over 7 years of follow-up: the SMART-MR study.

Kooistra M, Zuithoff NP, Grool AM, Zinsmeester M, Biessels GJ, van der Graaf Y, Geerlings MI; SMART-MR Study Group.

Psychol Med. 2015 Jun;45(8):1741-50. doi: 10.1017/S0033291714002864. Epub 2014 Dec 11.

PMID:
25499398
48.

A Critical Appraisal of the Hippocampal Subfield Segmentation Package in FreeSurfer.

Wisse LE, Biessels GJ, Geerlings MI.

Front Aging Neurosci. 2014 Sep 25;6:261. doi: 10.3389/fnagi.2014.00261. eCollection 2014. Review. No abstract available.

49.

The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: evidence of validity.

Frisoni GB, Jack CR Jr, Bocchetta M, Bauer C, Frederiksen KS, Liu Y, Preboske G, Swihart T, Blair M, Cavedo E, Grothe MJ, Lanfredi M, Martinez O, Nishikawa M, Portegies M, Stoub T, Ward C, Apostolova LG, Ganzola R, Wolf D, Barkhof F, Bartzokis G, DeCarli C, Csernansky JG, deToledo-Morrell L, Geerlings MI, Kaye J, Killiany RJ, Lehéricy S, Matsuda H, O'Brien J, Silbert LC, Scheltens P, Soininen H, Teipel S, Waldemar G, Fellgiebel A, Barnes J, Firbank M, Gerritsen L, Henneman W, Malykhin N, Pruessner JC, Wang L, Watson C, Wolf H, deLeon M, Pantel J, Ferrari C, Bosco P, Pasqualetti P, Duchesne S, Duvernoy H, Boccardi M; EADC-ADNI Working Group on The Harmonized Protocol for Manual Hippocampal Volumetry and for the Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Feb;11(2):111-25. doi: 10.1016/j.jalz.2014.05.1756. Epub 2014 Sep 27.

50.

Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophy.

Jochemsen HM, van der Flier WM, Ashby EL, Teunissen CE, Jones RE, Wattjes MP, Scheltens P, Geerlings MI, Kehoe PG, Muller M.

J Alzheimers Dis. 2015;44(1):153-62. doi: 10.3233/JAD-131496.

PMID:
25201786

Supplemental Content

Loading ...
Support Center